id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2954067,839d6d70-0954-4b63-9301-6462cf88cb6c,1A,"HEALTHCARE LEGAL RESOURCES NETWORK, LLC",401107302,"HEALTHCARE LEGAL RESOURCES NETWORK, LLC",2023,first_quarter,MED,Pharmaceutical,SENATE,,,0,0,2023-02-16T16:08:35-05:00
2954436,b71e6b5f-24b1-4fcb-82c6-453927dbbf86,Q1,"FRANCIS EDWARD & CRONIN, INC.",311314,CURE ALZHEIMER'S FUND,2023,first_quarter,MED,Legislation related to Alzheimer's disease research,"Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2023-04-01T14:01:26-04:00
2954437,f151587f-495e-4bb2-8f01-76760b6d7404,Q1,"FRANCIS EDWARD & CRONIN, INC.",311314,"PATH DECISION SUPPORT SOFTWARE, LLC",2023,first_quarter,MED,Legislation related to Diabetes Treament,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2023-04-01T14:04:50-04:00
2954457,57deaebd-c00c-4d2a-a122-668b8323731a,Q1,MARSHALL BRACHMAN,6848,BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM,2023,first_quarter,MED,support funding for medical research programs,"HOUSE OF REPRESENTATIVES,SENATE",33000,,0,0,2023-04-01T17:14:08-04:00
2954534,8c8724d0-9648-4e29-831d-000f190e0685,Q1,"OLD NORTH STRATEGIES, LLC",401106174,"EXELA PHARMA SCIENCES, LLC",2023,first_quarter,MED,supply chain & FDA issues,"HOUSE OF REPRESENTATIVES,SENATE",78000,,0,0,2023-04-02T20:43:21-04:00
2954586,1eadab89-9a43-4d85-8e7d-2f6af5c9767f,Q1,PENN AVENUE PARTNERS,400918672,"CLIFFSIDE LABS, LLC",2023,first_quarter,MED,Policy and regulatory matters related to the clinical laboratory industry.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2023-04-03T12:23:02-04:00
2954654,43cf3921-8137-4f70-8f2a-89475f4b828b,Q1,"MAGILL ASSOCIATES, LLC",401103511,THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES,2023,first_quarter,MED,FY 2023 and FY 2024 appropriations for the development of a synthetic vaccine,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2023-04-03T14:07:10-04:00
2954717,f881ca40-7f08-4056-9c51-c12171e7934b,Q1,"HELIX, INC.",401106164,"HELIX, INC.",2023,first_quarter,MED,"COVID-19, other respiratory pathogen sequencing and countermeasure development","Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office",,40000,0,0,2023-04-03T15:17:07-04:00
2954793,e9f0c1d6-b4ba-478b-8e6d-c663b3401960,Q1,"AUBURN HEALTH STRATEGIES, LLC",292697,AMERICAN PROFICIENCY INSTITUTE,2023,first_quarter,MED,proficiency testing for clinical laboratories,"Health & Human Services, Dept of (HHS)",,,0,0,2023-04-03T17:42:31-04:00
2954823,b676f214-cf09-4fbf-882a-2d12b2d8e581,Q1,OCAL LOBBYING GROUP,401106825,SAMERA S.A.,2023,first_quarter,MED,Obtain funding for Tuberculosis monitoring.,Natl Institutes of Health (NIH),,,0,0,2023-04-04T06:50:37-04:00
2954933,981401f4-82eb-4a58-af91-7513ea5b9914,Q1,THE HARRIS FIRM,68376,HOLISTIC INDUSTRIES INC.,2023,first_quarter,MED,Issues pertaining to cannabis CSA scheduling.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2023-04-04T13:36:30-04:00
2954955,ea7987a2-821b-420d-aa02-6080eb47367e,Q1,"UNIVERSITY OF MARYLAND, BALTIMORE (UMB)",401103161,"UNIVERSITY OF MARYLAND, BALTIMORE (UMB)",2023,first_quarter,MED,"ARPA-H, budget and agency location","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,10000,0,0,2023-04-04T15:22:28-04:00
2955045,b5ac3baa-373c-48bc-94e6-5921238710e6,Q1,WATKINS & EAGER PLLC,401104403,NATIONAL FRAGILE X FOUNDATION,2023,first_quarter,MED,Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF; Encourage Members to meet with constituents impacted by Fragile X.,"HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2023-04-05T11:04:52-04:00
2955123,fee4884b-f8ab-4153-b647-dc455ca8969f,Q1,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2023,first_quarter,MED,Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,144981,0,0,2023-04-05T13:39:08-04:00
2955588,5f565610-696f-4b2e-988f-4026cd1f26e9,Q1,"REPUBLIC CONSULTING, LLC",401016871,IQVIA,2023,first_quarter,MED,Monitor Health Data Policy.,"Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2023-04-06T15:41:57-04:00
2955872,35957d87-cd93-4e2c-a691-81d3fcf2ec70,Q1,DAVID GENCARELLI,15918,SANOTIZE RESEARCH & DEVELOPMENT CORPORATION,2023,first_quarter,MED,"Outreach to Department of Defense Military Research Military Command (MRDC),HHS and National INstitute of Allergy & Infectious Disease (NIAID)",Defense Threat Reduction Agency (DTRA),18000,,0,0,2023-04-07T15:13:57-04:00
2956327,5faad9bd-2dce-4a48-936e-693fa2981141,Q1,AMERICAN ASSOCIATION FOR CANCER RESEARCH,400601833,AMERICAN ASSOCIATION FOR CANCER RESEARCH,2023,first_quarter,MED,"Cancer research generally Increasing diversity in clinical trials Drug approval Pediatric cancer detection, treatment, and prevention","HOUSE OF REPRESENTATIVES,SENATE",,100000,0,0,2023-04-10T11:47:03-04:00
2957030,ab1d0986-3c1e-422a-922a-2641566e5147,Q1,IMPACT MANAGEMENT GROUP,401104137,ARKANSAS RESEARCH ALLIANCE,2023,first_quarter,MED,On behalf of client support continued and future funding for clinical research programs in Arkansas,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2023-04-11T12:23:21-04:00
2957037,e4f75591-c31b-491e-b9a0-684bcca6b7ea,Q1,"THE PETRIZZO GROUP, INC.",305932,OMEROS CORPORATION,2023,first_quarter,MED,Separate payment policies for non-opioid alternatives.,"HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2023-04-11T12:28:20-04:00
2957122,505f05b7-f1b0-4e9e-8c9d-9646af9104d9,Q1,SQUIRE PATTON BOGGS,30906,NATIONAL CANNABIS ROUNDTABLE,2023,first_quarter,MED,"Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.","HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of,White House Office",80000,,0,0,2023-04-11T13:56:59-04:00
2957164,eebd3e7a-8466-4586-ace8-508f3f468614,Q1,BEN BARNES GROUP LP,5415,HUNTSMAN CORPORATION,2023,first_quarter,MED,CMS Medicare,"HOUSE OF REPRESENTATIVES,SENATE",18750,,0,0,2023-04-11T14:14:48-04:00
2957184,d750eb62-08de-475e-9ed3-012f68286a38,Q1,BEN BARNES GROUP LP,5415,ENVIGO RMS LLC,2023,first_quarter,MED,Medical/Disease Research,"HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2023-04-11T14:23:25-04:00
2957188,39efe2cc-20ab-419d-bb29-c054ca3c746e,1T,BEN BARNES GROUP LP,5415,VIRON THERAPEUTICS,2023,first_quarter,MED,Covid/Virus treatments,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,1,2023-04-11T14:35:09-04:00
2957322,a1bdea7d-92af-42d1-a659-f7dadc0b2573,Q1,"THE PETRIZZO GROUP, INC.",305932,DYSAUTONOMIA INTERNATIONAL,2023,first_quarter,MED,"Advocate for NIH research funding for dysautonomia disorders, specifically Postural Orthostatic Tachycardia Syndrome (POTS) and funding to examine the correlation between POTS and Long COVID.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2023-04-11T16:05:15-04:00
2957419,b7ed9111-5dc8-46c7-8a12-3e1c2d1e1719,Q1,"THE PETRIZZO GROUP, INC.",305932,SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION,2023,first_quarter,MED,Increased funding for pediatric medical research,"HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2023-04-11T21:29:50-04:00
2957573,1a12c753-97e8-4a54-a861-d35307ae0862,Q1,"PARDES BIOSCIENCES, INC.",401106493,"PARDES BIOSCIENCES, INC.",2023,first_quarter,MED,NIH funding for clinical trials,Natl Institutes of Health (NIH),,120000,0,0,2023-04-12T10:25:50-04:00
2957577,7b178cfd-76ff-4ab0-bfa0-f3bee1a34931,2T,"PARDES BIOSCIENCES, INC.",401106493,"PARDES BIOSCIENCES, INC.",2023,second_quarter,MED,NIH funding for clinical trials,Natl Institutes of Health (NIH),,120000,0,1,2023-04-12T10:26:43-04:00
2957654,8182552a-e4de-47a2-98e1-6deaf1cc5181,Q1,ALPINE ADVISORS,401106595,"COALITION FOR CANNABIS POLICY, EDUCATION AND REGULATION",2023,first_quarter,MED,Issues pertaining to government-wide federal regulation of cannabis,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2023-04-12T11:53:49-04:00
2958173,f7f26b32-58c6-41d6-badf-5db14b769eeb,Q1,MARSHFIELD CLINIC HEALTH SYSTEM,57830,MARSHFIELD CLINIC HEALTH SYSTEM,2023,first_quarter,MED,"research support, agriculture, farm safety, child care and agriculture communities","HOUSE OF REPRESENTATIVES,SENATE",,70000,0,0,2023-04-12T18:57:20-04:00
2958282,72693b1a-5303-4b92-a13f-e33ff97c2fb9,Q1,COVINGTON & BURLING LLP,11195,"SL 2T, LLC (""SMARTLABS"")",2023,first_quarter,MED,"Education and support for policies and funding to advance turnkey, co-located, on-demand pharma grade research laboratory environments, including responses to House and Senate Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPA) Re-authorization RFI's.","HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2023-04-13T09:42:09-04:00
2958897,868c1f2f-e626-4bb3-986f-6df4bb34255a,Q1,"FEDERAL SOLUTIONS, LLC",311371,MISSISSIPPI STATE UNIVERSITY,2023,first_quarter,MED,Labor/HHS/Education Appropriations: Provisions relating to disease research,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2023-04-13T16:32:50-04:00
2959190,0dfdb3b9-7edf-4a79-bf1f-05d050187676,Q1,"THE CJR GROUP, INC.",288293,UNIVERSITY HOSPITALS HEALTH SYSTEM,2023,first_quarter,MED,Hospital at Home,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2023-04-14T09:44:10-04:00
2959338,a252b86e-938d-491a-88cd-e3d086c84c51,Q1,BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY),60218,BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY),2023,first_quarter,MED,Gabriella Miller Kids First Act (yet to be introduced); Implementation of the Childhood Cancer STAR Act (enacted in 2022);,"HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,130000,0,0,2023-04-14T11:37:54-04:00
2959853,340b9f70-8676-46ea-a521-04a287c59169,Q1,RAY C CULVER III,11468,ARKANSAS CHILDREN'S HOSPITAL,2023,first_quarter,MED,Funding for USDA ARS human nutrition research funding in the House and Senate FY24 appropriations bills.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2023-04-14T19:50:55-04:00
2959871,6f320e6a-fa16-4b71-9932-613f3a33ab72,Q1,"INVIVYD, INC.",401106767,"INVIVYD, INC.",2023,first_quarter,MED,education and awareness of COVID-19 therapeutics,"Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE",70000,,0,0,2023-04-15T04:46:09-04:00
2960120,75f68d6d-5516-4f19-b53e-985ec5632b18,Q1,AMERICAN SOCIETY OF ADDICTION MEDICINE,401104864,AMERICAN SOCIETY OF ADDICTION MEDICINE,2023,first_quarter,MED,"Advocated for increased FY24 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY24 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M) Joined coalition letters supporting increased FY24 funding for a variety of other SUD-related programs in FY24 at HRSA, SAMHSA, and CDC Advocated for (S. 644/H.R. 1359) the Modernizing Opioid Treatment Access Act, which would allow specially registered opioid treatment program clinicians and addiction specialist physicians to prescribe methadone for OUD that can be picked up from pharmacies, subject to federal regulation or guidance on supply of methadone for unsupervised use. Advocated for HR 2400- the Reentry Act, which would allow states to provide Medicaid coverage to eligible individuals up to 30 days prior to release from incarceration Supported S.971 - Due Process Continuity of Care Act, which would amend title XIX of the Social Security Act to remove the Medicaid coverage exclusion for inmates in custody pending disposition of charges, and for other purposes. Worked on draft legislation that would provide Medicare coverage for evidence-based residential SUD services Worked on draft legislation that would make permanent a state plan amendment option related to Medicaid's IMD exclusion Supported H.R.1502 - Comprehensive Opioid Recovery Centers Reauthorization Act of 2023, in its entirety Advocated for removal of in-person evaluation requirement in proposed telemedicine rules by the DEA and worked on related draft legislation Advocated for changes to proposed 42 CFR Part 8 rule governing methadone for opioid use disorder Provided recommendations for the 2024 biennial national drug control strategy in a letter to the Office of National Drug Control Policy (ONDCP). ASAM suggested inclusion in the 2024 strategy, a call for the decoupling criminal penalties and personal drug use possession, implemented as part of a carefully designed set of public health and legal reforms that include strategic, social investments to strengthen American communities and improve lives. Opposed proposed changes to the STAR-LRP program in S.462 - the Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023 Joined letter asking Congress to remove a lifetime ban that prevents individuals convicted of a drug felony from receiving Supplemental Nutritional Assistance Program (SNAP) or Temporary Assistance for Needy Families TANF) as part of the next Farm Bill. Joined letter in support for legislation to make Veterans Health Administration (VHA) facilities fully smoke-free. Provided comments to the Centers for Medicare and Medicaid Services (CMS) encouraging CMS to address the Medicare Physician Fee Schedule's (MPFS) physician payment methodology challenges in the next release of the MPFS in 2024. Sent letter to the U.S. Department of Health and Human Services' (HHS) Offices of the Secretary and Civil Rights, and the Substance Abuse and Mental Health Administration (SAMHSA), to provide comments on proposed modifications to 42 CFR Part 2 (""Part 2""), applauding policy efforts to further align Part 2 with the Health Insurance Portability and Accountability Act, recommending that HHS conduct a study of the impact of full alignment with HIPAA on the access, availability, and quality of SUD services, coupled with strengthened HIPAA protections against uses, disclosures, or redisclosures of SUD and other medical records outside the healthcare system, and cautioning the final rule make it clear, on a consistent basis, that Part 2 records may not be used, disclosed, or redisclosed for civil, criminal, administrative, or legislative proceedings against the patient in the absence of a court order or a specific, written patient consent for that purpose. Submitted comments to the Centers for Medicare and Medicaid Services (CMS) on its proposed rule regarding changes to the Medicare Advantage (MA) program for the 2024 plan year. In the letter, ASAM applauded CMS' proposals to strengthen beneficiaries' access to treatment for opioid use disorder (OUD), including proposals that address MA plans' crippling utilization management (UM) policies. ASAM urged CMS to finalize its proposals that limit the use of prior authorization (PA) to its utility in medical necessity determinations, require MA plans to institute UM review committees, and ensure sufficient training, experience and credentials in addiction care for those involved in the UM review process. ASAM also urged CMS to make additional changes surrounding MA plans' use of PA and recommended CMS finalize, with modifications, its update to MA plan network adequacy requirements to address the needs of people with substance use disorder (SUD).","Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)",,65000,0,0,2023-04-16T08:04:51-04:00
2960290,66ac7d57-49e9-4c00-99fc-04349c279e10,Q1,TIBER CREEK GROUP,20744,JAZZ PHARMACEUTICALS,2023,first_quarter,MED,Issues related to cannabis research; issues related to the FDA; issues related to Cannabis research at Health and Human Services.,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2023-04-16T16:34:53-04:00
2960387,69050538-827f-4204-a2fb-df0bb8239d52,Q1,CAPITOL COUNSEL LLC,313715,"UNIVERSITY OF MASSACHUSETTS, BOSTON",2023,first_quarter,MED,Advocacy related to federal funding for UMass Boston for healthcare workforce and sustainability educational projects in FY 2024 Appropriations legislation.,"Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2023-04-16T18:16:15-04:00
2960597,9401c6e9-ecc3-49a2-9b83-787818d89f4d,Q1,BROYDRICK & ASSOCIATES,7268,"NORTHSTAR RADIOISOTOPES, LLC",2023,first_quarter,MED,"DOE policies and cooperative agreements expansion legislation, Nuclear medicine CMS Reimbursement, NNSA reorganization. Funding for new cooperative agreements. NDAA provisions.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2023-04-17T09:39:47-04:00
2960613,b34a2147-ceb4-434f-b87b-0d060d183c10,Q1,THE CONSILIO GROUP,400374717,DETECTACHEM,2023,first_quarter,MED,Colorimetric explosive and narcotic detection capabilities,"Air Force, Dept of,Defense, Dept of (DOD),Education, Dept of,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,White House Office",16500,,0,0,2023-04-17T09:43:43-04:00
2960622,577582e3-b313-4997-953d-c21ff7c85860,Q1,IPOLICY SOLUTIONS,401105127,ASSOCIATION FOR MOLECULAR PATHOLOGY,2023,first_quarter,MED,No bill #: Verified Innovative Testing in American Laboratories Act H.R.2369 - VALID Act of 2023,"Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE",45000,,0,0,2023-04-17T09:46:58-04:00
2960655,db1dd3c1-a59f-4938-b0d5-dcdd6900978a,Q1,IPOLICY SOLUTIONS,401105127,INVITAE INC.,2023,first_quarter,MED,H.R.2369 - VALID Act of 2023,"HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2023-04-17T09:57:47-04:00
2960752,f92faf78-115a-4e7f-a973-6bed78cb5154,Q1,"F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES",18411,F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES,2023,first_quarter,MED,(MED) Clinical Lab Fee Schedule H.R. 2377 and S. 1000. Saving Access to Laboratory Services Act,"HOUSE OF REPRESENTATIVES,SENATE",,150000,0,0,2023-04-17T10:23:52-04:00
2960787,53ecd670-9924-4ce9-823d-a7709fcad12b,Q1,EMERGENT STRATEGIES,401104778,ADVAMED:ADVANCED MEDICAL TECHNOLOGY ASSOCIATION,2023,first_quarter,MED,"Health tax issues and trade, Issues related to Small Business Innovation Research Program","HOUSE OF REPRESENTATIVES,SENATE",45000,,0,0,2023-04-17T10:30:46-04:00
2960811,b02765f7-1d3a-4568-89ab-dcc5f15d156d,Q1,FORBES-TATE,400976792,AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION,2023,first_quarter,MED,Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2023-04-17T10:34:11-04:00
2960833,584a0660-0733-4318-ad0e-76449a0f7dcc,Q1,"COMPASS GOVERNMENT RELATIONS PARTNERS, LLC",401106533,"COALITION FOR INNOVATIVE LABORATORY TESTING, INC.",2023,first_quarter,MED,VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses; re-introduced in Spring of 2023 as H.R.2639,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2023-04-17T10:45:00-04:00
2960855,78dea111-b47f-4a88-9517-775899ee2f57,Q1,"COMPASS MANAGEMENT PARTNERS, INC.",401105171,THE LIVING LEGACY FOUNDATION OF MARYLAND,2023,first_quarter,MED,Regulations impacting accountability requirements at organ procurement organizations; organ donation matters,,,,0,0,2023-04-17T10:49:41-04:00
2960927,b9b09bc1-68f0-4182-b739-8c7f1022ae7f,Q1,FORBES-TATE,400976792,"AMGEN USA, INC.",2023,first_quarter,MED,Issues related to Biosimilars; Issues related to drug pricing; Issues related to H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2023-04-17T11:00:19-04:00
2961066,3307ff14-5ff9-47f0-9865-3777c020ebdf,Q1,O'NEILL AND ASSOCIATES,73134,"POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN)",2023,first_quarter,MED,"Healthcare, Medical","HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2023-04-17T11:20:09-04:00
2961215,d97b0982-a0a6-4041-911b-22349328b2da,Q1,FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC),86196,"INTUITIVE SURGICAL, INC.",2023,first_quarter,MED,Lobbying related to health care issues.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2023-04-17T11:47:54-04:00
2961253,c5a77d0d-1c67-46a8-b0f5-4307932dbcc0,Q1,IMPACT MANAGEMENT GROUP,401104137,"CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC.",2023,first_quarter,MED,Supporting the passage of H.R. 3173 - Improving Seniors' Timely Access to Care Act of 2021,HOUSE OF REPRESENTATIVES,,,0,0,2023-04-17T11:53:56-04:00
2961257,ba81b86f-1295-41e4-a223-e0db04fda87c,Q1,FORBES-TATE,400976792,CALIFORNIA LIFE SCIENCES ASSOCIATION,2023,first_quarter,MED,Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2023-04-17T11:54:08-04:00
2961357,6cd88782-074b-4b17-b7c5-3262778b33cf,Q1,BRAMER GROUP LLC,401103355,"TACTICAL MEDICAL SOLUTIONS, LLC",2023,first_quarter,MED,FY2023 and FY2024 NDAA,"Army, Dept of (Other),Defense, Dept of (DOD)",8250,,0,0,2023-04-17T12:11:25-04:00
2961398,b2c4520d-09fc-4f7f-95f3-91e033ef0c83,Q1,FORBES-TATE,400976792,"COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION",2023,first_quarter,MED,Issues pertaining to government-wide federal regulation of cannabis.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2023-04-17T12:18:17-04:00
2961468,bbf202bc-aeef-47fc-8a53-cf394aa81a7b,Q1,FORBES-TATE,400976792,CSL BEHRING,2023,first_quarter,MED,Issues related to Rx pricing.,"HOUSE OF REPRESENTATIVES,SENATE",120000,,0,0,2023-04-17T12:30:02-04:00
2961542,2ef8add6-e89e-4895-91ad-d9745e17338f,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,DEFENSE HEALTH RESEARCH CONSORTIUM,2023,first_quarter,MED,"FY24 Defense Appropriations Act, Defense Health Research Programs","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2023-04-17T12:48:02-04:00
2961572,72c6a468-501e-4589-ac8d-c0d20488656b,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,PANCREATIC CANCER ACTION NETWORK (PANCAN),2023,first_quarter,MED,"FY24 Defense Appropriations Act, Peer-Reviewed Pancreatic Cancer Research Program; FY24 Labor HHS Education Act, NIH research on pancreatic cancer","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2023-04-17T12:56:00-04:00
2961586,82e7df4f-2fb8-4bab-9f98-0ebdeda7353b,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,FOUNDATION FOR PERIPHERAL NEUROPATHY,2023,first_quarter,MED,"FY24 Defense Appropriations Act, DoD funding for peripheral neuropathy research; FY24 Labor HHS Education Appropriations Act, NIH research on peripheral neuropathy","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2023-04-17T12:59:09-04:00
2961850,a41f0d47-2f5b-4ee5-83a5-69b98bc8be39,Q1,SQUIRE PATTON BOGGS,30906,ALLIANCE FOR BIOSECURITY,2023,first_quarter,MED,Preparedness and response as it relates to Biosecurity.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",100000,,0,0,2023-04-17T14:03:08-04:00
2961956,94d5951b-55f2-4fb1-9862-d32f4e8f4ceb,Q1,HACKENSACK MERIDIAN HEALTH,401104109,HACKENSACK MERIDIAN HEALTH,2023,first_quarter,MED,National Institutes of Health funding Biomedical research and ARPA-H Support for the Center for Discovery and Innovation,"HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,160000,0,0,2023-04-17T14:36:31-04:00
2962059,378e7e3b-f658-428a-b1c5-9786f5d656c5,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,TUBEROUS SCLEROSIS ALLIANCE,2023,first_quarter,MED,"FY24 Defense Appropriations Act, Tuberous Sclerosis Complex Research Program; FY24 Labor HHS Education Act, NIH and CDC funding for tuberous sclerosis complex research and surveillance.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2023-04-17T14:59:26-04:00
2962064,bb993eb5-873a-4fc0-9fb1-8188282611c5,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,KIDNEYCAN,2023,first_quarter,MED,"FY24 Labor-HHS-Education Appropriations Act, kidney cancer research at NIH","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2023-04-17T15:01:03-04:00
2962078,1849a360-29c0-4f22-8df6-52c18490d346,Q1,AMERICAN PHYSICAL THERAPY ASSOCIATION,3093,AMERICAN PHYSICAL THERAPY ASSOCIATION,2023,first_quarter,MED,"NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding PT role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention Outpatient Therapy Modernization and Stabilization Act","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,266282,0,0,2023-04-17T15:02:47-04:00
2962085,99d7fe78-a2fb-46f8-a40e-1b4405973530,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,VHL ALLIANCE,2023,first_quarter,MED,"FY24 Defense Appropriations Act, DoD research on Von Hippel-Lindau syndrome; FY24 Labor HHS Education Act, NIH research on Von Hippel-Lindau syndrome.","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2023-04-17T15:03:05-04:00
2962091,c5db8370-d2a6-419d-bfb2-a34b187a691b,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,VHL ALLIANCE,2023,first_quarter,MED,"FY24 Defense Appropriations Act, DoD research on Von Hippel-Lindau syndrome; FY24 Labor HHS Education Act, NIH research on Von Hippel-Lindau syndrome.","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2023-04-17T15:04:56-04:00
2962566,b7fc39f8-47ec-496c-9db3-519e2a77c5b8,Q1,SQUIRE PATTON BOGGS,30906,"LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC.",2023,first_quarter,MED,Funding support for federally qualified health centers; reauthorization of programs,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2023-04-17T16:46:36-04:00
2962693,5cb4c6cd-4340-4d9b-a9ac-a0c53d3d74a4,Q1,AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS,52105,AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS,2023,first_quarter,MED,Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries,"HOUSE OF REPRESENTATIVES,SENATE",,431429,0,0,2023-04-17T17:17:12-04:00
2962762,06c81031-65cd-4a32-af17-d148680058a8,Q1,"VARIAN MEDICAL SYSTEMS, INC.",400359648,"VARIAN MEDICAL SYSTEMS, INC.",2023,first_quarter,MED,Right to Repair Artificial Intelligence for Medical Devices Health care workforce PACT Act Physician Fee Schedule/Reimbursement Issues,"HOUSE OF REPRESENTATIVES,SENATE",,240000,0,0,2023-04-17T17:48:21-04:00
2962961,38ee7760-3dd9-4a34-82b4-ab3aa76db7ce,Q1,CAPITOL COUNSEL LLC,313715,"BLUE EARTH DIAGNOSTICS, INC.",2023,first_quarter,MED,To gain support for adequate Medicare reimbursement for diagnostic radiopharmaceuticals; H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2023-04-17T21:12:02-04:00
2962969,31fd640c-ddbc-4843-ae02-52d606aaadc8,Q1,CAPITOL COUNSEL LLC,313715,"EMD SERONO, INC.",2023,first_quarter,MED,Issues regarding the availability and pricing of prescription drugs.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2023-04-17T21:25:23-04:00
2962997,388bdd11-f24d-4085-99f1-ff2da07bd672,Q1,CAPITOL COUNSEL LLC,313715,MASSACHUSETTS BIOTECHNOLOGY COUNCIL,2023,first_quarter,MED,Monitor health and tax legislation pertaining to the biotechnology industry.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2023-04-17T22:05:24-04:00
2963059,a88c4477-2cc4-45f4-9057-99cd7cdb27e6,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,ADVANCED MEDICAL TECHNOLOGY ASSOCIATION,2023,first_quarter,MED,Congressional outreach related to health care issues.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2023-04-17T23:27:53-04:00
2963314,2a83cbd8-437c-4bf2-99fd-71868810c832,Q1,BLUEBIRD STRATEGIES,401105447,"MYRIAD GENETICS, INC.",2023,first_quarter,MED,Legislation to regulate clinical labs under CLIA and FDA.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2023-04-18T09:27:57-04:00
2963334,5464273d-8432-4f29-9a4b-11c0213f8a03,Q1,BLUEBIRD STRATEGIES,401105447,MYOTONIC,2023,first_quarter,MED,Increasing funding for Myotonic Dystrophy research. Fiscal Year 2024 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2023-04-18T09:36:04-04:00
2963574,346e28eb-7dc7-4c25-9126-4c52e7ffe585,Q1,MICHIGAN TECHNOLOGICAL UNIVERSITY,25181,MICHIGAN TECHNOLOGICAL UNIVERSITY,2023,first_quarter,MED,Discussed issues of interest related to higher education for the COVID-19 pandemic.,"HOUSE OF REPRESENTATIVES,SENATE",,60000,0,0,2023-04-18T10:33:12-04:00
2963576,3b73b80f-f255-479b-8f25-e7d37837b75f,Q1,"BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER)",292538,SONIC HEALTHCARE USA,2023,first_quarter,MED,"Issues relating to the regulation of laboratory developed tests, the VALID Act, issues relating to PAMA (the SALSA Bill), federal policies relating to the implementation of the anti-kickback requirements of the Support for Patients and Communities Act. Physician Lab Fee schedule. Anatomic Fee Schedule and Surprise Billing. COVID Testing and billing procedures. COVID Vaccine Federal Mandate.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2023-04-18T10:33:24-04:00
2964198,09d31607-7ada-4781-aba8-1ce3e731d626,Q1,"BECKER & POLIAKOFF, P.A.",283696,UNIVERSITY OF MIAMI,2023,first_quarter,MED,Cancer Research Grants,"Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2023-04-18T12:35:21-04:00
2964351,d7e89502-7b81-4f82-8656-86f22d5bab36,Q1,STRATEGIC MARKETING INNOVATIONS,60550,ICHOR SCIENCES,2023,first_quarter,MED,Defense appropriations programmatic add,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2023-04-18T13:15:59-04:00
2964599,5eeb7015-fcd4-4725-b1c5-f864fcb491a7,Q1,"POWERS PYLES SUTTER & VERVILLE, P.C.",32008,HERBERT J. THOMAS MEMORIAL HOSPITAL ASSOCIATION (FKA THOMAS HEALTH),2023,first_quarter,MED,"Consolidated Appropriations Act, FY 2022, H.R. 2741, now P.L. 117-103 (FY 2022 CDS Implementation) FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Commerce and Justice, Science and Related Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Departments of Transportation, Housing and Urban Development and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Primary Care, Behavioral Health and Related Providers House, Senate Legislation to Fund Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund Behavioral Health Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine/Telehealth in Hospitals House, Senate Infrastructure Bills","Administration for Children & Families (ACF),Administration on Aging,Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Appalachian Regional Commission,Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of",30000,,0,0,2023-04-18T14:02:32-04:00
2964699,cd1c75ba-cf3f-4f26-a8aa-bdc841030c6d,Q1,"POWERS PYLES SUTTER & VERVILLE, P.C.",32008,"CORNERSTONE CARE, INC.",2023,first_quarter,MED,"Consolidated Appropriations Act, 2023, H.R. 2617, now P.L. 117-328 FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Commerce and Justice, Science and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Primary Care and Other Providers House, Senate Legislation to Fund Substance Use Disorder and Behavioral Health Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Infrastructure Bills","Appalachian Regional Commission,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of",,,0,0,2023-04-18T14:18:06-04:00
2964783,be731535-2d4b-413c-8fd4-16bd215b9700,1T,"BROWNSTEIN HYATT FARBER SCHRECK, LLP",7257,COLUMBIA CARE LLC,2023,first_quarter,MED,"Issues relating to cannabis research, including the DEA August 12, 2016, solicitation of applications to manufacture cannabis for research purposes (Docket No. DEA-447)","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,1,2023-04-18T14:33:33-04:00
2964999,c79088c2-0e93-4fdc-86bf-528ed244b0f7,Q1,GOLDBUG STRATEGIES LLC,400701094,COALITION FOR 21ST CENTURY MEDICINE,2023,first_quarter,MED,"in vitro diagnostics, clinical laboratories, digital health regulation","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2023-04-18T15:17:37-04:00
2965013,a4d32522-e54d-4a07-9326-5bdb3705ec03,Q1,WASHINGTON UNIVERSITY IN ST. LOUIS,40031264,WASHINGTON UNIVERSITY IN ST LOUIS,2023,first_quarter,MED,General advocacy for NIH and other biomedical research. General advocacy supporting the continued responsible utilization of research animals.,"HOUSE OF REPRESENTATIVES,SENATE",,10000,0,0,2023-04-18T15:21:52-04:00
2965050,50ed654a-5da6-475f-ab23-991fe5bb7b54,1A,WIDERCHANGE LLC,401107228,PHOENIX ZONES INITIATIVE,2023,first_quarter,MED,HR 1024 Humane and Existing Alternatives in Research and Testing Sciences Act of 2022 or the HEARTS Act of 2022 and issues related to the FDA Modernization Act of 2021. Brief conversations with staff members discussed patient benefits of modernize medical testing.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2023-04-18T15:31:20-04:00
2965093,81bbb75b-633c-4f07-8919-d1b13a05d44e,Q1,"POWERS PYLES SUTTER & VERVILLE, P.C.",32008,GATEWAYS HOSPITAL & MENTAL HEALTH CENTER FOUNDATION,2023,first_quarter,MED,"Consolidated Appropriations Act, 2023, H.R. 2617, now P.L. 117-328 FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Commerce and Justice, Science and Related Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Departments of Transportation, Housing and Urban Development and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Behavioral Health and Related Providers House, Senate Legislation to Fund Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund Behavioral Health Care Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Infrastructure Bills","Administration for Children & Families (ACF),Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Bureau of Justice Assistance,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Justice, Dept of (DOJ),Office of Justice Program,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)",20000,,0,0,2023-04-18T15:40:50-04:00
2965242,2bef9286-898e-4c25-853a-b73b4bbd5f9d,Q1,STANFORD UNIVERSITY,36492,STANFORD UNIVERSITY,2023,first_quarter,MED,Issues related to health equity and social determinants of health HR 2389 Resident Physician Shortage Reduction Act of 2023 HR 459 - SAFER Health Act,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,90000,0,0,2023-04-18T15:54:28-04:00
2965299,af0a98f7-4ab8-405f-a0b7-a21fca4f555f,Q1,"POWERS PYLES SUTTER & VERVILLE, P.C.",32008,PIH HEALTH FOUNDATION,2023,first_quarter,MED,"Consolidated Appropriations Act, 2023, H.R. 2617, now P.L. 117-328 FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Primary Care and Other Providers House, Senate Legislation to Fund Substance Use Disorder and Behavioral Health Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Implement Electronic Provider Consultations(E-Consults) with Related Telemedicine in Hospitals House, Senate Infrastructure Bills","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)",30000,,0,0,2023-04-18T16:05:57-04:00
2965731,2d355787-a3fc-451f-93bf-c1a25ab0f7c4,Q1,"TWENTY-FIRST CENTURY GROUP, INC.",38687,GLOBAL ALZHEIMER'S PLATFORM INNOVATIONS PBC,2023,first_quarter,MED,Issues related to diversity in clinical trials and Alzheimers research.,"HOUSE OF REPRESENTATIVES,SENATE",24000,,0,0,2023-04-18T17:10:36-04:00
2965750,8e469d4f-0538-4d13-af44-9dc789ca1ff3,Q1,"TWENTY-FIRST CENTURY GROUP, INC.",38687,NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX),2023,first_quarter,MED,Research and treatment related to suicide prevention for veterans and patients with bipolar depression.,"HOUSE OF REPRESENTATIVES,SENATE",24000,,0,0,2023-04-18T17:15:44-04:00
2965889,90ff8e06-f1c6-458f-91be-678ab9fe17d9,Q1,"THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)",2970,"THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)",2023,first_quarter,MED,none,,,160000,0,0,2023-04-18T17:46:36-04:00
2965959,0610986b-303c-43da-8ecf-cc29d6111271,Q1,ARENTFOX SCHIFF LLP,4208,INFECTIOUS DISEASES SOCIETY OF AMERICA,2023,first_quarter,MED,"Draft legislation (PASTEUR Act), all provisions","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2023-04-18T18:10:52-04:00
2966065,ef383513-f7b8-4c36-a9c3-9c7df8cf0e8e,Q1,"OAK RIDGE ASSOCIATED UNIVERSITIES, INC.",401104196,"OAK RIDGE ASSOCIATED UNIVERSITIES, INC.",2023,first_quarter,MED,FY24 HHS / CDC Appropriations,"Health & Human Services, Dept of (HHS)",,30000,0,0,2023-04-18T18:30:23-04:00
2966467,012c48fe-0a63-43b5-9948-95312fc13bbc,Q1,"BROWNSTEIN HYATT FARBER SCHRECK, LLP",7257,MARIDOSE LLC,2023,first_quarter,MED,"Issues relating to cannabis research, including the DEA Aug. 12 2016 solicitation of applications to manufacture cannabis for research purposes (Docket No. DEA-447)","Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE",,,0,0,2023-04-18T23:03:16-04:00
2966663,8bf2077a-2aac-4d81-bf08-d9478f2b8011,Q1,STRATEGIC MARKETING INNOVATIONS,60550,PSYONIC,2023,first_quarter,MED,Receive DoD medical research funding on how to best apply prosthetic to the nervous system,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2023-04-19T08:08:18-04:00
2966708,0b7c3b7d-129a-4114-bc30-4c49fbdcd140,Q1,"BOLD STRATEGIES, LLC",401104653,PENNINGTON BIOMEDICAL RESEARCH CENTER,2023,first_quarter,MED,Obesity and COVID research. Appropriations.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2023-04-19T08:39:22-04:00
2967218,8a403bd0-f390-4027-bc89-1e9be69000d5,Q1,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2023,first_quarter,MED,Support for robust funding for federal agencies that fund medical and disease research,"HOUSE OF REPRESENTATIVES,SENATE",,50000,0,0,2023-04-19T10:06:02-04:00
2967460,06d3020d-454e-4f2e-b0bd-a6ecca3b7487,Q1,PARALYZED VETERANS OF AMERICA,30724,PARALYZED VETERANS OF AMERICA,2023,first_quarter,MED,"Discussions: Department of Veterans Affairs, Medical Research Issues Discussions: National Institutes of Health, Medical Research Issues","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)",,88885,0,0,2023-04-19T10:25:30-04:00
2967562,5214cc8c-7747-498d-886c-5efcde6ae459,Q1,TURNER & GOSS LLP,316310,CYSTIC FIBROSIS FOUNDATION,2023,first_quarter,MED,PASTEUR Act (HR 3932 and S 2076 in previous Congress; to be reintroduced),"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2023-04-19T10:34:30-04:00
2967814,d559fa7b-dc62-462c-86c2-dba211a7328a,Q1,STRATEGIES 360,79175,"INNOVA MEDICAL GROUP, INC.",2023,first_quarter,MED,Issues related to the FDA approval process for medical testing,,30000,,0,0,2023-04-19T10:51:51-04:00
2968066,ca9daedc-8490-4013-a04f-77f35f04edf6,Q1,VAN SCOYOC ASSOCIATES,39837,"ARUP LABORATORIES, INC.",2023,first_quarter,MED,"H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other purposes, Diagnostic Lab Testing Laboratory Testing related issues Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Clinical Laboratory Improvement Amendments (CLIA), generally Pandemic All Hazards Preparedness Act, generally Monitor CURES 2.0, Diagnostic Lab Testing issues","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2023-04-19T11:11:09-04:00